Colonnade Acquisition Corp. II (NYSE:CLAA – Get Rating) was the recipient of a significant increase in short interest during the month of November. As of November 30th, there was short interest totalling 62,200 shares, an increase of 296.2% from the November 15th total of 15,700 shares. Based on an average daily trading volume, of 97,400 shares, the days-to-cover ratio is presently 0.6 days.

Colonnade Acquisition Corp. II Stock Performance

Shares of CLAA stock remained flat at $10.00 during trading on Monday. The company had a trading volume of 32,724 shares, compared to its average volume of 77,355. The stock's 50 day simple moving average is $9.97 and its 200-day simple moving average is $9.89. Colonnade Acquisition Corp. II has a fifty-two week low of $9.67 and a fifty-two week high of $10.05.

Institutional Investors Weigh In On Colonnade Acquisition Corp. II

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. BNP Paribas Arbitrage SNC acquired a new stake in Colonnade Acquisition Corp. II in the third quarter valued at $8,932,000. Mizuho Securities USA LLC acquired a new stake in Colonnade Acquisition Corp. II during the 3rd quarter worth about $5,144,000. Aristeia Capital LLC acquired a new stake in Colonnade Acquisition Corp. II during the 2nd quarter worth about $3,740,000. Credit Suisse AG acquired a new stake in Colonnade Acquisition Corp. II during the 3rd quarter worth about $1,984,000. Finally, Bank of Montreal Can acquired a new stake in Colonnade Acquisition Corp. II during the 2nd quarter worth about $1,236,000. 64.75% of the stock is currently owned by institutional investors.

About Colonnade Acquisition Corp. II

Colonnade Acquisition Corp. II focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in West Palm Beach, Florida.

Further Reading

• Get a free copy of the StockNews.com research report on Colonnade Acquisition Corp. II (CLAA)
• Three Small-Cap Biotech Stocks to Consider Now
• What To Expect From The Q4 Earnings Reporting Season
• Two Blue Chip Health Companies The Institutions Are Buying
• Here's What to Expect for the S&P 500 in 2023
• Can Bilibili be the Chinese Version of YouTube?

Receive News & Ratings for Colonnade Acquisition Corp. II Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colonnade Acquisition Corp. II and related companies with MarketBeat.com's FREE daily email newsletter.